Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
293,061,432
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
104,032,627
-
Shares change
-
-3,738,353
-
Total reported value, excl. options
-
$524,646,193
-
Value change
-
+$3,617,959
-
Put/Call ratio
-
68%
-
Number of buys
-
76
-
Number of sells
-
57
-
Price
-
$5.03
Institutional Holders of AbCellera Biologics Inc. - Ordinary Shares (ABCL) as of Q3 2025
As of 30 Sep 2025 AbCellera Biologics Inc. - Ordinary Shares (ABCL) had 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 104,032,627 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, Capital World Investors, BAILLIE GIFFORD & CO, TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, ArrowMark Colorado Holdings LLC, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, and TANG CAPITAL MANAGEMENT LLC.
This table shows 140 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.